{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:18:15Z","timestamp":1769761095530,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,27]],"date-time":"2018-05-27T00:00:00Z","timestamp":1527379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00277-018-3375-9","type":"journal-article","created":{"date-parts":[[2018,5,27]],"date-time":"2018-05-27T01:29:05Z","timestamp":1527384545000},"page":"1803-1808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-4406","authenticated-orcid":false,"given":"Matteo","family":"Molica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Scalzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioia","family":"Colafigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo Alunni","family":"Fegatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latagliata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,27]]},"reference":[{"issue":"2","key":"3375_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/leu.2010.215","volume":"25","author":"E Jabbour","year":"2011","unstructured":"Jabbour E, Deininger M, Hochhaus A (2011) Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Leukemia 25(2):201\u2013210","journal-title":"Leukemia"},{"issue":"7","key":"3375_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/1042819031000079140","volume":"44","author":"M Pou","year":"2003","unstructured":"Pou M, Saval N, Vera M, Saurina A, Sol\u00e9 M, Cervantes F, Botey A (2003) Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia. Leuk Lymphoma 44(7):1239\u20131241","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3375_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5301\/jo-n.5000008","volume":"1","author":"VS Barta","year":"2017","unstructured":"Barta VS, Uppal NN, Pullman JM, Levy AT, Jhaveri KD (2017) Acute tubular injury associated with imatinib (Gleevec): a case report and review of the literature. J Onco-Nephrol 1(1):57\u201361","journal-title":"J Onco-Nephrol"},{"issue":"9","key":"3375_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/annonc\/mdq715","volume":"22","author":"MS Marcolino","year":"2011","unstructured":"Marcolino MS, Boersma E, Clementino NC et al (2011) Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients. Ann Oncol 22(9):2073\u20132079","journal-title":"Ann Oncol"},{"issue":"21","key":"3375_CR5","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1002\/cncr.29587","volume":"121","author":"M Yilmaz","year":"2015","unstructured":"Yilmaz M, Lahoti A, O'Brien S, Nogueras-Gonz\u00e1lez GM, Burger J, Ferrajoli A, Borthakur G, Ravandi F, Pierce S, Jabbour E, Kantarjian H, Cortes JE (2015) Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer 121(21):3894\u20133904","journal-title":"Cancer"},{"issue":"5","key":"3375_CR6","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0002-9440(10)65484-3","volume":"155","author":"T Nakagawa","year":"1999","unstructured":"Nakagawa T, Sasahara M, Haneda M, Kataoka H, Nakagawa H, Yagi M, Kikkawa R, Hazama F (1999) Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am J Pathol 155(5):1689\u20131699","journal-title":"Am J Pathol"},{"key":"3375_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)63651-6","volume":"163","author":"M Takikita-Suzuki","year":"2003","unstructured":"Takikita-Suzuki M, Haneda M, Sasahara M, Owada MK, Nakagawa T, Isono M, Takikita S, Koya D, Ogasawara K, Kikkawa R (2003) Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury. Am J Pathol 163:277\u2013286","journal-title":"Am J Pathol"},{"key":"3375_CR8","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa051140","volume":"354","author":"E Berman","year":"2006","unstructured":"Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, Wilson BA, Heller G, Sauter NP (2006) Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med 354:2006\u20132013","journal-title":"N Engl J Med"},{"issue":"9","key":"3375_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y(L), Castro AF III, Feldman HI, Kusek JW, Eggers P, van Lente F, Greene T, Coresh J, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"key":"3375_CR10","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 39(2 Suppl 1):S1\u2013S266"},{"issue":"2","key":"3375_CR11","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31","journal-title":"Crit Care"},{"issue":"1","key":"3375_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2007050532","volume":"19","author":"J Floege","year":"2008","unstructured":"Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19(1):12\u201323","journal-title":"J Am Soc Nephrol"},{"issue":"5 Pt 1","key":"3375_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0895-7061(00)01290-5","volume":"14","author":"H Kishioka","year":"2001","unstructured":"Kishioka H, Fukuda N, Wen-Yang H et al (2001) Effects of PDGF A-chain antisense oligodeoxynucleotides on growth of cardiovascular organs in stroke-prone spontaneously hypertensive rats. Am J Hypertens 14(5 Pt 1):439\u2013445","journal-title":"Am J Hypertens"},{"issue":"1","key":"3375_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.ki.5001528","volume":"70","author":"C Zoja","year":"2006","unstructured":"Zoja C, Corna D, Rottoli D, Zanchi C, Abbate M, Remuzzi G (2006) Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 70(1):97\u2013103","journal-title":"Kidney Int"},{"issue":"7","key":"3375_CR15","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1073\/pnas.89.7.2873","volume":"89","author":"T Doi","year":"1992","unstructured":"Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1992) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A 89(7):2873\u20132877","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3375_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.ATV.0000124105.39900.db","volume":"24","author":"M Lassila","year":"2004","unstructured":"Lassila M, Allen TJ, Cao Z et al (2004) Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 24(5):935\u2013942","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3375-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T19:05:36Z","timestamp":1558897536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,27]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3375-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,27]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}